参与物
| 角色 | 名称 | HCID | 投料 |
|---|
| 反应物 | 叔丁醇 | HCID 6386 | — |
| 反应物 | N,N'-二环己基碳二亚胺 | HCID 10868 | — |
| 反应物 | 四碘甲状腺乙酸 | HCID 65552 | — |
| 催化剂 | 4-二甲氨基吡啶(DMAP) | HCID 14284 | — |
| 溶剂 | 1,4-二氧六环 | HCID 31275 | — |
| 产物 | tert-Butyl-2-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)acetate | HCID 44224192 | 10% |
反应步骤
In anhydrous conditions, Tetrac (30.0 g, 40.1 mmol, 1.0 eq.) was dissolved in anhydrous dioxane (200 mL). Tert-butyl alcohol (11.4 mL, 120.3 mmol, 3.0 eq.) and 4-dimethylaminopyridine (3.9 g, 32.1 mmol, 0.8 eq.) were then added. The solution was stirred and dicyclohexylcarbodiimide (9.1 g, 44.1 mmol, 1.1 eq.) was added over a 5 minutes period. The mixture was stirred for 3 hours at room temperature. The cyclohexylurea that has precipitated was removed by filtration through a fritted Büchner funnel, and the filtrate was washed with 10% potassium bicarbonate solution (2×100 mL). During this procedure, some additional cyclohexylurea precipitated and was removed by filtration of both layers to facilitate their separation. The organic solution was then dried over magnesium sulfate, filtered and then evaporated with a rotary evaporator to obtain the crude product as a yellow powder which was purified by column chromatography (DCM/cyclohexane 90/10) to yield tert-butyl-2-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)acetate (3.2 g, 4.0 mmol) as a solid.
来源与证据
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 专利号 | US08802240B2 |
|---|
| 来源数据集 | uspto-grants-2014_08 |
|---|
| ORD ID | ord-063a440dee1d4bde91da9574c7d8ef6e |
|---|
| 来源说明 | uspto-grants-2014_08 |
|---|